The slip
PARKINSON RECEIPTno. 6919
22 Oct 2026, 23:25 UTCastrocytes, braak
predictionTGFB2 in astrocytes tracks Braak Lewy-body stage
registeredb143c44e69d7411b
discovery-0.01 p=0.982 n=9
replication-0.14 p=0.725 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.01, p 0.982)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTf88b5e6a2ecb9bf180e63e1d…
follows 0c4ab71b0079…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6919: TGFB2 in astrocytes, braak
- power
- full sample +0.06 (p 0.807, n 18), 95% CI -0.42 to +0.51. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.04 (p 0.888, n 18). does not hold up.
- composition
- astrocytes share of nuclei vs axis -0.21 (p 0.413); controlling for it: +0.01 (p 0.969, n 18). could be the mix.
- skeptic
- leave-one-out range -0.08 to +0.16, sign flips 4; without severely affected donors +0.06 (p 0.807, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TGFB2 in astrocytes.
case closed: nothing better to follow up.